CN1340057A - 干扰细胞内信号发生的合成多肽 - Google Patents
干扰细胞内信号发生的合成多肽 Download PDFInfo
- Publication number
- CN1340057A CN1340057A CN00803727A CN00803727A CN1340057A CN 1340057 A CN1340057 A CN 1340057A CN 00803727 A CN00803727 A CN 00803727A CN 00803727 A CN00803727 A CN 00803727A CN 1340057 A CN1340057 A CN 1340057A
- Authority
- CN
- China
- Prior art keywords
- peptide
- acid
- amino
- cell
- methionin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (11)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP8643A AUPP864399A0 (en) | 1999-02-12 | 1999-02-12 | A synthetic peptide that disturbs intracellular signaling |
AUPP8643 | 1999-02-12 | ||
KR1999/20282 | 1999-06-02 | ||
KR1019990020282A KR20010001214A (ko) | 1999-06-02 | 1999-06-02 | 세포내 신호전달을 조절하는 합성 펩타이드 및 이를 포함하는암치료 및 면역억제용 약학조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1340057A true CN1340057A (zh) | 2002-03-13 |
CN1262561C CN1262561C (zh) | 2006-07-05 |
Family
ID=36406633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008037272A Expired - Fee Related CN1262561C (zh) | 1999-02-12 | 2000-02-12 | 干扰细胞内信号发生的合成多肽 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1150995B1 (zh) |
JP (1) | JP3819712B2 (zh) |
KR (1) | KR100409264B1 (zh) |
CN (1) | CN1262561C (zh) |
AT (1) | ATE315045T1 (zh) |
CA (1) | CA2362464A1 (zh) |
DE (1) | DE60025332T2 (zh) |
DK (1) | DK1150995T3 (zh) |
ES (1) | ES2254137T3 (zh) |
WO (1) | WO2000047607A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317093B (zh) * | 2005-12-20 | 2012-09-19 | 夏普株式会社 | 用于结合配体的新的捕获试剂 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7348181B2 (en) | 1997-10-06 | 2008-03-25 | Trustees Of Tufts College | Self-encoding sensor with microspheres |
WO2009074569A1 (en) * | 2007-12-11 | 2009-06-18 | Bracco International Bv | Targeting and therapeutic compounds with a polyproline-comprising spacer and gas-filled microvesicles comprising said compounds |
CN101393217B (zh) * | 2008-09-27 | 2012-05-30 | 中国人民解放军第二军医大学 | 一种原发性肝癌血清标志物的检测试剂盒 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5976819A (en) * | 1995-11-21 | 1999-11-02 | National Jewish Medical And Research Center | Product and process to regulate actin polymerization in T lymphocytes |
US7815749B2 (en) * | 2006-06-29 | 2010-10-19 | Hitachi Metals, Ltd. | Method for manufacturing semi-hard magnetic material and semi-hard magnetic material |
-
2000
- 2000-02-12 KR KR10-2001-7002733A patent/KR100409264B1/ko not_active IP Right Cessation
- 2000-02-12 DK DK00904109T patent/DK1150995T3/da active
- 2000-02-12 DE DE60025332T patent/DE60025332T2/de not_active Expired - Fee Related
- 2000-02-12 WO PCT/KR2000/000107 patent/WO2000047607A1/en active IP Right Grant
- 2000-02-12 ES ES00904109T patent/ES2254137T3/es not_active Expired - Lifetime
- 2000-02-12 CN CNB008037272A patent/CN1262561C/zh not_active Expired - Fee Related
- 2000-02-12 CA CA002362464A patent/CA2362464A1/en not_active Abandoned
- 2000-02-12 AT AT00904109T patent/ATE315045T1/de not_active IP Right Cessation
- 2000-02-12 JP JP2000598524A patent/JP3819712B2/ja not_active Expired - Fee Related
- 2000-02-12 EP EP00904109A patent/EP1150995B1/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317093B (zh) * | 2005-12-20 | 2012-09-19 | 夏普株式会社 | 用于结合配体的新的捕获试剂 |
Also Published As
Publication number | Publication date |
---|---|
JP3819712B2 (ja) | 2006-09-13 |
ATE315045T1 (de) | 2006-02-15 |
EP1150995B1 (en) | 2006-01-04 |
EP1150995A1 (en) | 2001-11-07 |
DK1150995T3 (da) | 2006-05-22 |
WO2000047607B1 (en) | 2000-10-26 |
KR20010100802A (ko) | 2001-11-14 |
CN1262561C (zh) | 2006-07-05 |
KR100409264B1 (ko) | 2003-12-12 |
DE60025332D1 (de) | 2006-03-30 |
JP2003522116A (ja) | 2003-07-22 |
WO2000047607A1 (en) | 2000-08-17 |
CA2362464A1 (en) | 2000-08-17 |
DE60025332T2 (de) | 2006-07-06 |
ES2254137T3 (es) | 2006-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10538555B2 (en) | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | |
CN103215328B (zh) | 转谷氨酰胺酶介导的肽的接合 | |
TWI250988B (en) | Thrombopoietic compounds | |
US20160158349A1 (en) | Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions | |
AU2018385697A1 (en) | Stabilized peptide-mediated targeted protein degradation | |
CN1374969A (zh) | Fap活化的抗肿瘤化合物 | |
AU2021217353A1 (en) | IL-7Rαγc binding compounds | |
Rubin et al. | Backbone-cyclized peptides: a critical review | |
JP2008502301A (ja) | ペプチドの抱合 | |
TW200526780A (en) | TNF antagonists and TNF inhibitors comprising the same as the active ingredient | |
CN1871022A (zh) | 结合血小板生成素受体的肽和化合物 | |
AU2003213140A1 (en) | Compositions and compounds for use as molecular adjuvant for a nicotine vaccine | |
JP2010536923A (ja) | タンパク質を選択的に修飾するための組成物と方法 | |
US6030942A (en) | Peptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductase | |
CN1340057A (zh) | 干扰细胞内信号发生的合成多肽 | |
US10246488B2 (en) | Use of inhibitory peptides for the treatment of inflammatory diseases | |
TW200838558A (en) | New immunomodulating oligopeptides | |
JP5594691B2 (ja) | 改変タンパク質 | |
AU642487B2 (en) | Neutrophil stimulating peptides | |
JP5529014B2 (ja) | 部位特異的なペグ化をされた直鎖状のサケカルシトニン類似体 | |
JPH10505835A (ja) | 特定の細胞型への化学試薬の細胞内送達 | |
US20240158448A1 (en) | Multivalent nano-'self' peptides and uses thereof | |
US20140005119A1 (en) | COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS | |
CN1264862C (zh) | 白喉毒素-促性腺激素释放素嵌合蛋白质 | |
ES2575629T3 (es) | Polipéptido del Factor VIII |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YIN ZHENGHE; HAN YONGTAI Effective date: 20020906 Owner name: SAITONSY CO., LTD. Free format text: FORMER OWNER: JIN JIXIAN |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20020906 Address after: Seoul City, Korea Applicant after: Saituoxisi Co. Ltd. Address before: Seoul City, Korea Applicant before: Jin Jixian Co-applicant before: Yin Zhenghe Co-applicant before: Han Yongtai |
|
ASS | Succession or assignment of patent right |
Owner name: BOOKER WANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SAITONSY CO., LTD. Effective date: 20050826 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050826 Address after: Seoul Applicant after: Kim Gil Hyon Address before: Seoul City, Korea Applicant before: Saituoxisi Co. Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |